Far infared Treatment for kidney diseases

Who do you know who might need hear about this? It's too late for my mom.....although she had cancer she died of kidney failure. The attending physician, a young man, said it was most likely caused by arthritis medication taken over the years which destroys kidney functionality. Back then at least, the arthritis doctors poo pooed this explanation. They were wrong and did a grave mis-service to the patients who trusted them by refusing to check out the new data.Our products are now endorsed for superior and safe pain relief associated with Lyme's Disease by the Lyme's Disease Coalition. Who do you know who can benefit from their information?Our products have recently been used to avoid surgical amputation by increasing circulation and destroying infections/bacteria (one a bone infection and other deep tissue infections and bed sores). The US Navy and military, NASA, and Univ of Wis Oncology Dept, among others, relies on light therapy for accelerated wound healing and pain relief in extreme situations. The Univ of Wis led by Dr Harry Whelan, has many studies ongoing including for macular degeneration, skin infections, diabetic ulcers, and many more. Their products made for medical (non-surgical) conditions obtained FDA approval by 'piggy-backing' on our products FDA approval; ie., the technical components are the same. (The price is very different!!)For our info go to www.lightsoundtechnology.com and www.lightfortherapy.com (has videos).Sincerely, Jana Sullivan
Infra Red Kidney Study
Far Infrared Treatment for Kidney Diseases
This study is ongoing at the time of this post, but not recruiting participants.
Sponsored by: GAAD Medical Research Institute Inc.
Information provided by: GAAD Medical Research Institute Inc.
ClinicalTrials.gov Identifier: NCT00599391
Purpose
Renal failure or kidney failure is a situation in which the kidneys fail to function adequately. It is divided into acute and chronic forms; either form may be due to a large number of other medical problems.
Condition Intervention Phase
Kidney Failure Radiation: Far Infrared Radiation (5µm to 20µm wavelength) Phase I

MedlinePlus related topics: Kidney Failure
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title: Phase 1 Study to Examine the Use of Far Infrared Radiation for Renal Failure.

Further study details as provided by GAAD Medical Research Institute Inc.:
Primary Outcome Measures:
Kidney Function Improvement [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
Causes of Mortality [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 10
Study Start Date: February 2008
Estimated Study Completion Date: February 2009
Estimated Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1
Far Infrared Radiation Radiation: Far Infrared Radiation (5µm to 20µm wavelength)
Far Infrared Radiation for 30 to 40 minutes per session.
Detailed Description:
There are many causes of chronic kidney disease. The most common cause is diabetes mellitus. Acute renal failure is a rapidly progressive loss of renal function, generally characterized by body fluids disturbances and electrolyte derangement.
It is believed that far infrared radiation of the central nervous system, the endocrine system and the kidneys will help in the management of renal failure and a possible cure.
Eligibility
Genders Eligible for Study: Both Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria:
People with kidney diseases
Exclusion Criteria:
None
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00599391Locations Canada, Ontario
The Centre for Incurable Diseases Toronto, Ontario, Canada, M4V 1L5
Sponsors and Collaborators
GAAD Medical Research Institute Inc.
Investigators
Study Chair: Ken Nedd, M.D. GAAD Medical Research Institute Inc.
Study Director: Kwasi Donyina, Ph.D. GAAD Medical Research Institute Inc.
More Information
Responsible Party: GAAD Medical Research Institute Inc. ( Dr. Kwasi Donyina/Founder and President )
Study ID Numbers: GAAD-RF-CTP1
Study First Received: January 11, 2008
Last Updated: January 2, 2009
ClinicalTrials.gov Identifier: NCT00599391
Health Authority: Canada: Health Canada
Keywords provided by GAAD Medical Research Institute Inc.:
KIDNEY FAILURE, ACUTE KIDNEY FAILURE, CHRONIC RENAL INSUFFICIENCY
Study placed in the following topic categories:
Renal Insufficiency Urologic Diseases Kidney Failure, Chronic Kidney Failure, Acute Kidney Diseases Kidney FailureClinicalTrials.gov processed this record on January 26, 2009